US FDA Granted Biostar Pharma's IND Application to Initiate Phase 2/3 Trial of Utidelone Injectable to Treat NSCLC

US FDA Granted Biostar Pharma’s IND Application to Iiostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. announced that, after having in-depth discussions with the FDA through pre-IND meetings, the FDA has approved...

Lupin Introduces Thiamine Hydrochloride Injection USP in US markets

Global pharma major Lupin Limited (Lupin) announced the launch of thiamine hydrochloride injection USP, 200 mg/2 mL (100 mg/mL) multiple-dose vials, after Lupin’s alliance partner Caplin Steriles Limited (Caplin) received an approval for its ANDA....

Zucara Therapeutics to get US$ 2 million additional funding from JDRF to support ZT-01 phase 2 study

Zucara Therapeutics Inc., a diabetes-focused life sciences company developing the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced additional funding from JDRF, the leading global....

Why Pharmaceutical Packaging is Crucial for Drug Safety

Any product that needs to be transported must include packaging. It aids in preventing damage during delivery, offers the details required to get to its target location, and even prioritizes the security of the handlers and customers.

Quantiphi Collaborates with Pharmarack and Snowflake to revolutionize India's pharma industry with AI-driven innovation

Quantiphi, an AI-first digital engineering firm, announced a collaboration with Pharmarack, India's leading integrated B2B healthcare tech platform, and Snowflake, the Data Cloud startup, today. This collaboration will transform Pharmarack's....

Sanofi Consumer Healthcare Introduces New Portal To Unlock Science and Solve Key Challenges in Self-care

Sanofi's Consumer Healthcare Business Unit has launched a new Open Innovation Portal, which allows the supply chain community to submit creative, disruptive, and game-changing solutions to meet the challenges of an ever-changing consumer...

Glenmark Cuts Price of Breast Cancer Drug Trastuzumab; 440 mg Vial will now be Priced at Rs 15,749

Pharma Glenmark Pharmaceuticals, a major pharmaceutical company, announced a price drop for Trastuzumab. The medicine is used to treat HER2-positive breast cancer and is known as 'Trumab' in India. Trumab's 440 mg vial will now cost Rs 15,749....

ACROBiosystems Aneuro Collaborates With Diagnostic Biochips To Accelerate Neuroscience Drug Discovery

ACROBiosystems recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips via ACRO Certify and its Aneuro brand. Two companies have agreed to work together to accelerate neurological....

PLI Programmes in Pharma Sector Attracts Investment Of Rs. 21,861 Crore till March, 2023

The three production linked incentive (PLI) schemes in the pharmaceuticals and medical devices sector have attracted a total investments to the tune of Rs. 21,861 crore till March, 2023, with majority of the investments going into the PLI scheme...

Sudhansh Pant Appointed as the New Union Health Secretary

Sudhansh Pant, a senior IAS officer, has been named the new Health Secretary as part of the Centre's top-level bureaucratic reshuffle on Tuesday. Pant, a Rajasthan cadre Indian Administrative Service (IAS) officer from the 1991 batch,...

© 2025 India Pharma Outlook. All Rights Reserved.